Jane Street’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-450,435
Closed -$329K – 12949
2026
Q2
$333K Sell
450,435
-729,646
-62% -$554K ﹤0.01% 8993
2026
Q1
$817K Buy
1,180,081
+501,621
+74% +$370K ﹤0.01% 6937
2025
Q4
$483K Buy
678,460
+522,205
+334% +$710K ﹤0.01% 7763
2025
Q3
$253K Sell
156,255
-219,813
-58% -$221K ﹤0.01% 9236
2025
Q2
$230K Buy
376,068
+357,801
+1,959% +$182K ﹤0.01% 8321
2025
Q1
$10.4K Sell
18,267
-6,872
-27% -$6.78K ﹤0.01% 9201
2024
Q4
$35.9K Sell
25,139
-5,667
-18% -$12.7K ﹤0.01% 9047
2024
Q3
$59.5K Sell
30,806
-33,479
-52% -$94.5K ﹤0.01% 9139
2024
Q2
$199K Buy
64,285
+3,487
+6% +$14.4K ﹤0.01% 8535
2024
Q1
$318K Buy
60,798
+45,357
+294% +$217K ﹤0.01% 7614
2023
Q4
$50K Sell
15,441
-4,559
-23% -$9.8K ﹤0.01% 8939
2023
Q3
$51K Sell
20,000
-71,776
-78% -$300K ﹤0.01% 8322
2023
Q2
$539K Buy
+91,776
New +$533K ﹤0.01% 6335
2023
Q1
– Sell
-12,501
Closed -$25.1K – 10113
2022
Q4
$25.1K Buy
+12,501
New +$30.5K ﹤0.01% 8733

Other funds holding TNYA

Jane Street's TNYA Position: Q3 2026 in Review

Jane Street sold out of Tenaya Therapeutics (TNYA) in Q3 2026, closing a stake of 450,435 shares — an estimated $329K sold.

Jane Street first reported a position in TNYA in Q4 2022 and held it in 14 quarters. The position peaked at $817K in Q1 2026. 97 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

  • Jane Street reported no remaining Tenaya Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jane Street sold 450,435 Tenaya Therapeutics shares in Q3 2026, an estimated $329K.
  • Jane Street first reported a position in Tenaya Therapeutics in Q4 2022 and held it in 14 quarters.
  • Jane Street's Tenaya Therapeutics position peaked at $817K in Q1 2026.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.